Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 19, 2025 • 2:21 PM ET

Date/Time Source News Release
06/12/2025 08:00 AM EDT Business Wire Cadrenal Therapeutics Highlights New Research on Anticoagulation Burden for LVAD Patients
06/04/2025 08:00 AM EDT Business Wire Cadrenal Therapeutics to Engage Potential Partners at BIO International Convention 2025
05/15/2025 07:30 AM EDT Business Wire Cadrenal Therapeutics Announces Tecarfarin Manufacturing Progress in Support of Clinical Trial Readiness
05/08/2025 08:00 AM EDT Business Wire Cadrenal Therapeutics Reports First-Quarter 2025 Financial Results and Provides Corporate Update
04/03/2025 08:00 AM EDT Business Wire Cadrenal Therapeutics Participates in Key Medical and Business Development Conferences
03/13/2025 04:05 PM EDT Business Wire Cadrenal Therapeutics Reports Full Year 2024 Results, Business Highlights, and Path Forward for Clinical Advancement of Tecarfarin
03/04/2025 08:00 AM EST Business Wire Cadrenal Therapeutics Announces Collaboration Agreement with Abbott in Support of Pivotal Study of Tecarfarin in Patients with HeartMate 3(TM) LVAD
02/06/2025 09:00 AM EST Business Wire Cadrenal Therapeutics Announces Chief Medical Officer Transition to Advance Clinical Development of Tecarfarin
02/05/2025 09:00 AM EST Business Wire Cadrenal Therapeutics to Present at BIO CEO & Investor Conference
01/09/2025 08:44 AM EST Business Wire Cadrenal Therapeutics to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025
Page

Additional News

As of June 19, 2025 • 2:21 PM ET

Date/Time Source News Release
05/08/2025 09:59 AM EDT SeekingAlpha Cadrenal Therapeutics GAAP EPS of -$2.09 misses by $0.45
05/08/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Thursday, May 8th, 2025
05/08/2025 05:31 AM EDT US Earnings Reports Expected earnings - Cadrenal Therapeutics Inc.
03/13/2025 04:58 PM EDT SeekingAlpha Cadrenal Therapeutics GAAP EPS of -$8.73 misses by $1.14
03/10/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Monday, March 10th, 2025
03/10/2025 05:30 AM EDT US Earnings Reports Expected earnings - Cadrenal Therapeutics Inc.
12/09/2024 10:36 PM EST Stock Traders Daily (CVKD) Trading Report
11/29/2024 07:00 AM EST Stock Traders Daily Learn to Evaluate (CVKD) using the Charts
11/15/2024 04:38 AM EST US Earnings Reports Expected earnings - Cadrenal Therapeutics Inc.
11/14/2024 04:46 PM EST SeekingAlpha Cadrenal Therapeutics files to sell 590,001 shares of common stock for holders
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.